Levobupivacaine hydrochloride and sufentanil have no antimicrobial effect at 25°C in vitro

被引:8
作者
Guillier, M.
Boselli, E. [1 ]
Bouvet, L.
Freney, J.
Renaud, F. N. R.
Chassard, D.
Allaouchiche, B.
机构
[1] Hop Edouard Herriot, Dept Anaestheisol & Intens Care, F-69003 Lyon, France
[2] Univ Lyon 1, ISPB, Nosoco Tech, EA 3090, Lyon, France
关键词
antimicrobial agents; levobupivacaine; sufentanil; anaesthesia conduction; colony count; microbial;
D O I
10.1017/S0265021507000178
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background and objectives: Levobupivacaine in combination with sufentanil may be used for labour or postoperative regional analgesia. The risk of bacterial growth within these contained solutions for several hours at room temperature is unknown. We investigated the in vitro antimicrobial effect of levobupivacaine and sufentanil against common micro-organisms encountered during regional anaesthesia. Methods: Standardized suspensions of Staphylococcus aureus, Staphylococcus epidermidis and Escherichia coli were incubated for 1, 3, 6 and 24h at 25 degrees C, with saline (as control), sufentanil 0.5 or 0.75 mu g mL(-1), levobupivacaine hydrochloride 5.6 mg mL(-1) and concentrations of 1.4, 2.8 and 5 mg mL(-1) of levobupivacaine hydrochloride with sufentanil 0. 5 mu g mL(-1) Colony counts were compared after 24 h incubation at 37 degrees C. Results: No bacterial growth was observed on any bacterial strain for any solution tested throughout the experiment. Conclusions: Our results suggest that solutions of levobupivacaine combined with sufentanil may be used for 24 h at room temperature during regional anaesthesia with no risk of bacterial growth.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 28 条
  • [1] Antimicrobial activity of ropivacaine and other local anaesthetics
    Aydin, ON
    Eyigor, M
    Aydin, N
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2001, 18 (10) : 687 - 694
  • [2] Bacterial growth in ropivacaine hydrochloride
    Bátai, I
    Kerényi, M
    Falvai, J
    Szabó, G
    [J]. ANESTHESIA AND ANALGESIA, 2002, 94 (03) : 729 - 731
  • [3] The impact of drugs used in anaesthesia on bacteria
    Bátai, I
    Kerényi, M
    Tekeres, M
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1999, 16 (07) : 425 - 440
  • [4] Neurologic complications of 405 consecutive continuous axillary catheters
    Bergman, BD
    Hebl, JR
    Kent, J
    Horlocker, TT
    [J]. ANESTHESIA AND ANALGESIA, 2003, 96 (01) : 247 - 252
  • [5] Pain relief and motor function during continuous interscalene analgesia after open shoulder surgery: a prospective, randomized, double-blind comparison between levobupivacaine 0.25%, and ropivacaine 0.25% or 0.4%
    Borghi, B.
    Facchini, F. E.
    Agnoletti, V.
    Adduci, A.
    Lambertini, A.
    Marini, E.
    Gallerani, P.
    Sassoli, V.
    Luppi, M.
    Casati, A.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2006, 23 (12) : 1005 - 1009
  • [6] Antibacterial activity of clonidine and neostigmine in vitro
    Boselli, E
    Guillier, M
    Freney, J
    Mazoyer, MA
    Casoli, E
    Renaud, FRN
    Rimmelé, T
    Chassard, D
    Allaouchiche, B
    [J]. ANESTHESIA AND ANALGESIA, 2005, 101 (01) : 121 - 124
  • [7] Diamorphine and bupivacaine mixtures: an in vitro study of microbiological safety
    Cook, TM
    James, PA
    Stannard, CF
    [J]. PAIN, 1998, 76 (1-2) : 259 - 263
  • [8] The continuous femoral nerve block catheter for postoperative analgesia: Bacterial colonization, infectious rate and adverse effects
    Cuvillon, P
    Ripart, J
    Lalourcey, L
    Veyrat, E
    L'Hermite, J
    Boisson, C
    Thouabtia, E
    Eledjam, JJ
    [J]. ANESTHESIA AND ANALGESIA, 2001, 93 (04) : 1045 - 1049
  • [9] Antibacterial activity of anesthetic solutions and preservatives - An in vitro comparative study
    Dantas, PEC
    Uesugui, E
    Nishiwaki-Dantas, MC
    Mimica, LJ
    [J]. CORNEA, 2000, 19 (03) : 353 - 354
  • [10] FELDMAN JM, 1994, REGION ANESTH, V19, P43